Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Dodge & Cox Stock Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"Dodge & Cox Stock Fund outperformed the S&P 500's challenging Q1 (-4.3%) with a 3.54% gain, benefiting from a rotation to value stocks and a strong recovery in contrarian healthcare holdings like CVS."
Dodge & Cox Stock Fund (Class I) posted a positive return of 3.54% for Q1 2025, significantly outperforming the S&P 500, which fell 4.3% in its worst quarterly performance in more than two years. Outperformance was driven by a reversal in the 'Magnificent Seven' and a shift from growth to value. Health Care, the Fund's worst-performing sector in 2024, became the largest contributor in Q1 2025, supported by a strong 50%+ rebound in CVS Health. The Fund proactively added to Industrials, Materials, Real Estate, and Health Care, while trimming Financials. Despite early April market volatility fueled by the Trump administration's tariff rollouts, the managers encourage a long-term outlook and remain confident in the Fund's low relative valuation (14.1x forward P/E).
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Dodge & Cox Stock Fund outperformed the S&P 500's challenging Q1 (-4.3%) with a 3.54% gain, benefiting from a rotation to value stocks and a strong recovery in contrarian healthcar...
Growth Outlook
Market outlook remains above average conviction: Dodge & Cox Stock Fund outperformed the S&P 500's challenging Q1 (-4.3%) with a 3.54% gain, benefiting from a rotation to value stocks and a strong recovery in contrarian healthcar...
Risk Appetite
Risk appetite posture is above average conviction: Dodge & Cox Stock Fund outperformed the S&P 500's challenging Q1 (-4.3%) with a 3.54% gain, benefiting from a rotation to value stocks and a strong recovery in contrarian healthcar...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Dodge & Cox Stock Fund outperformed the S&P 500's challenging Q1 (-4.3%) with a 3.54% gain, benefiting from a rotation to value stocks and a strong recovery in contrarian healthcar...
Forward Guidance
Forward guidance signal: Dodge & Cox Stock Fund outperformed the S&P 500's challenging Q1 (-4.3%) with a 3.54% gain, benefiting from a rotation to value stocks and a strong recovery in contrarian healthcar...
Language Signal
Tone analysis indicates above average conviction language: Dodge & Cox Stock Fund outperformed the S&P 500's challenging Q1 (-4.3%) with a 3.54% gain, benefiting from a rotation to value stocks and a strong recovery in contrarian healthcar...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. Dodge & Cox Stock Fund outperformed the S&P 500's challenging Q1 (-4.3%) with a 3.54% gain, benefiting from a rotation to value stocks and a strong recovery in contrarian healthcar...
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. Dodge & Cox Stock Fund outperformed the S&P 500's challenging Q1 (-4.3%) with a 3.54% gain, benefiting from a rotation to value stocks and a strong recovery in contrarian healthcar...
Time Horizon
Investment time horizon reflects a high conviction orientation. Dodge & Cox Stock Fund outperformed the S&P 500's challenging Q1 (-4.3%) with a 3.54% gain, benefiting from a rotation to value stocks and a strong recovery in contrarian healthcar...
